|
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
|
|
Satoru Matsuda1,
Hirofumi Kawakubo1,
Yuko Kitagawa1 |
|
1Department of Surgery, Keio University School of Medicine |
 |
|
| Although the development of multidisciplinary treatment for esophagogastric junction (EGJ) cancer is in progress, the recommended treatment varies from institution to institution and from country to country. The Upper GI Oncology Summit was held at the 15th International Gastric Cancer Congress in June 2023 with the aim of publishing Clinical Practice Guidelines. A total of 49 expert panel members (EPMs) were selected from each country in the fields of surgery, endoscopy, and internal medicine. A systematic review team (SR) independent of the EPMs was formed to evaluate the evidence for each clinical question (CQ). This guideline was developed in accordance with the Minds Clinical Practice Guideline Development Manual, and the GRADE grid method was used for consensus building. Through the meticulous discussion, a final vote was held on-site on the day of the Upper GI Oncology Summit. For the three CQs that did not reach 70% consensus, a final vote was held later on the Web to determine the level of recommendation. While this guideline is expected to help establish the standard of care for esophagogastric junction cancer in each region, there are large regional and institutional differences in the details of surgical and endoscopic techniques and in the selection of chemotherapy regimens, and further treatment development is expected. |
Index Term 1: Esophagogasctic junction cancer
Index Term 2: Guidelines
|
| Page Top |